Work

Supplementary Figure S4 from The Discovery and Characterization of HBS-101, a Novel Inhibitor of Midkine, as a Therapeutic Agent for the Treatment of Triple-Negative Breast Cancer

Year: 2025

Type: supplementary-materials

Abstract: Supplementary Figure S4: A-B, MDA-MB-231 (A), and BT-549 (B), cells were treated with HBS-101, stained with Annexin V, and analyzed by flow cytometry. Scatter plots illustrate Annexin V staining in control and HBS-101-treated cells.

DOI: 10.1158/1535-7163.30028855

Authors: Megharani Mahajan, Alondra L. Rodriguez Sanchez, Sridharan Jayamohan, Dileep K. Vijayan, Jessica D. Johnson, Huan Xie, Yang Wang, Dong Liang, John R. Sanchez, Panneerdoss Subbarayalu, Manjeet K. Rao, Ratna K. Vadlamudi, Gangadhara R. Sareddy, Hareesh B. Nair, Suryavathi Viswanadhapalli

Language: English

Topic: Cancer Mechanisms and Therapy

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4413905623

Cites:

Cited by:

Related to: 10